Business · 17/06/2015
FDA Announces Proposed Collection of Information for Automated Blood Cell Separator Device
The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, related to the development of a guidance document for the Automated Blood Cell Separator Device.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →